The bacteriophage product is a mass product. One sales opportunity lies in primary poultry production. Regular investigations show that up to 50% of retail poultry meat carry Campylobacter contaminations. Hence, big retailers have a high interest to deliver their customers flawless goods free from unwanted contaminations. In addition to supplying the bacteriophage product to the primary producer, post-harvest poultry processing sectors are identified. This development will improve the safety of poultry meat, reducing thereby the incidence of poultry-borne food poisoning, without impacting on animal welfare. In the US, Intralytix has garnered GRAS recognition from the FDA for a phage product targeting campylobacter, showcasing a feasible regulatory approval route for market entry. The application concentration of the product is rather high, presenting a potential price advantage for the C-sniper technology.